• iRGD-RBC Membranes Improve Neuroblastoma PDT

  2026-08-11

  A 2026 study developed iRGD-functionalized red blood cell membrane vesicles to deliver the photosensitizer TPOR in neuroblastoma models. The biomimetic carrier improved cellular uptake, apoptosis induction, migration inhibition, and tumor growth control compared with free TPOR, supporting targeted membrane-based delivery as a strategy for strengthening photodynamic therapy.

• AZ505: An Assay-First Guide to SMYD2 Inhibition

  2026-08-11

  AZ505 is a potent and selective SMYD2 inhibitor that connects substrate-competitive enzyme pharmacology with disease-relevant epigenetic regulation research. This assay-first guide explains how to interpret its potency, selectivity, cellular activity, and translational value in fibrosis and cancer biology research.

• Ceruletide Workflows for Pancreatic Fibrosis

  2026-08-10

  Ceruletide, also known as Caerulein or cerulein, offers a controllable CCK-receptor stimulus for pancreatic injury, fibrosis, and gastrointestinal physiology studies. This practical guide connects reagent handling and assay design with emerging MFGE8-based antifibrotic research while emphasizing controls, reproducibility, and troubleshooting.

• Tetraethylammonium Chloride: From Pore to Physiology

  2026-08-09

  Tetraethylammonium chloride (TEAC) is more than a broad potassium-channel blocker: it is a strategic perturbation tool for connecting pore access, ion conduction, cellular excitability, and vascular or neurophysiological phenotypes. This article translates the mechanism into experimental design guidance while defining the limits of cross-domain interpretation.

• Bradykinin: From Vascular Signal to Translation

  2026-08-08

  Bradykinin is more than a vasodilator peptide: it is a controllable physiological challenge for studying endothelial relaxation, vascular permeability, smooth muscle responses, pain, and inflammation. This thought-leadership article connects vascular assay design with the TRPM7/calcineurin/Drp1 mitochondrial mechanism reported in diabetic cognitive dysfunction while clearly separating established evidence from hypothesis-generating translational opportunities.

• PF-573228: FAK Inhibitor Workflow Guide

  2026-08-07

  Use PF-573228 to connect focal adhesion signaling with matrix mechanics, cancer-cell behavior, and angiogenesis phenotypes. This practical guide combines pathway validation, migration assays, odontoblast-like differentiation workflows, and troubleshooting for more interpretable FAK inhibition studies.

• D-Luciferin Sodium Salt: Advancing Firefly Luciferase Imagin

  2026-08-07

  D-Luciferin sodium salt is driving the evolution of ATP-dependent bioluminescence assays with unmatched sensitivity and reproducibility, especially for in vivo monitoring of cell metabolism and immunotherapy workflows. This article explores the latest experimental innovations, protocol optimizations, and troubleshooting strategies that set APExBIO’s D-Luciferin sodium salt apart for oncology and cell biology applications.

• Biomimetic Microparticles Disrupt Tumor pH for Chemo-Immunot

  2026-08-06

  This study introduces a biomimetic microparticle system co-delivering syrosingopine and a doxorubicin prodrug to simultaneously disrupt intracellular and extracellular pH homeostasis in tumor cells. The approach enhances both chemotherapeutic cytotoxicity and anti-tumor immune responses, offering a synergistic strategy to overcome immune suppression in the tumor microenvironment.

• Tetrandrine Alkaloid: Next-Gen Ion Channel Modulation in Res

  2026-08-06

  Explore how Tetrandrine, a bioactive alkaloid, is advancing ion channel modulation and neuroinflammation research. This article offers a novel, comparative perspective on Tetrandrine's mechanisms and research workflows, setting it apart from prior coverage.

• IMPDH Inhibition Suppresses PEDV Replication via Host Metabo

  2026-08-05

  This study reveals that porcine epidemic diarrhea virus (PEDV) hijacks host IMPDH-dependent guanine nucleotide biosynthesis to facilitate its replication. Both genetic and pharmacological inhibition of IMPDH, including with Merimepodib (VX-497), significantly reduces PEDV proliferation, highlighting a promising host-directed antiviral target for veterinary coronaviruses.

• Influenza Hemagglutinin (HA) Peptide: Evidence-Based Tag Uti

  2026-08-05

  Influenza Hemagglutinin (HA) Peptide is a rigorously validated epitope tag used in protein detection and purification. Its high solubility, stability, and specificity enable precise immunoprecipitation with anti-HA antibodies. This article details the biological rationale, mechanism, benchmarks, and workflow parameters for optimal HA tag peptide use.

• CUDC-907: Dual PI3K and HDAC Inhibitor for Cell Studies

  2026-08-04

  CUDC-907 is a dual PI3K and HDAC inhibitor suited for in vitro cancer research, enabling simultaneous modulation of critical cell signaling and epigenetic pathways. It is not intended for diagnostic, clinical, or therapeutic applications, and its use is strictly limited to controlled laboratory workflows. Researchers should use this compound for studies of cell cycle arrest and apoptosis, with attention to storage and solubility constraints.

• Z-IETD-FMK in Apoptosis Research: Beyond Caspase-8 Inhibitio

  2026-08-04

  Explore the advanced utility of Z-IETD-FMK, a potent caspase-8 inhibitor, in dissecting apoptosis and immune cell activation. This article delves into unique experimental strategies and recent insights, setting it apart as an essential guide for researchers in cell death and immune modulation.

• Targeting DHHC9-Mediated STRN4 Palmitoylation in Cancer Meta

  2026-08-03

  This study identifies DHHC9-mediated palmitoylation of STRN4 as a critical driver of YAP-dependent cancer metastasis. Pharmacological inhibition of DHHC9 suppresses tumor cell migration by disrupting the Hippo pathway, offering a novel therapeutic target for adenocarcinoma intervention.

• Structure-Based Discovery of Natural Inhibitors for SARS-CoV

  2026-08-03

  This article analyzes a structure-based virtual screening study that identified thymopentin and oleuropein as potent natural product inhibitors of the SARS-CoV-2 NSP15 endoribonuclease. The findings highlight the potential of computational drug discovery for targeting viral immune evasion and inform future antiviral strategies.

15358 records 1/1024 page Next 12345 下5页 Last page